Editor: What To Know
- “He brings a depth of expertise and experience leading accounting operations for a range of healthcare companies, including global organizations.
- He also served as vice president, controller and chief accounting officer at Alere, Inc.
- , a point-of-care diagnostics company which was acquired by Abbott in 2016.
Jonathan Wygant will report to Rebecca Chambers, Veracyte’s chief financial officer.
Jonathan Wygant will oversee all aspects of the company’s global accounting operations, financial reporting, and tax functions.
“We are thrilled to welcome Jonathan to Veracyte,” said Ms. Chambers. “He brings a depth of expertise and experience leading accounting operations for a range of healthcare companies, including global organizations. As we advance our global strategic vision, his accounting leadership will be critical to ensuring our organization’s continued success.”
Mr. Wygant most recently served as corporate controller at Biosplice Therapeutics, Inc. (formerly Samumed, LLC), a clinical-stage biotechnology company. In this role, he led all finance, accounting and reporting functions within the company.
Prior to that, Mr. Wygant was the chief financial officer at Cibus Global, LLC, where he oversaw the company’s financial operations. He also served as vice president, controller and chief accounting officer at Alere, Inc., a point-of-care diagnostics company which was acquired by Abbott in 2016.
Prior to that, Mr. Wygant held various leadership roles at CareFusion, including senior vice president, controller and chief accounting officer.
